| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xoma Royalty Corp (XOMA) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. XOMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $55.41M | - | |
| CEO | 102.0K | $4.27M | - | |
| CFO | 30.1K | $1.26M | - | |
| CFO | 30.0K | $1.26M | - | |
| Dir | 23.8K | $998.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2016 | Neal James R76 | VP Business Development | Sell | 2,500 | $0.45 | $1,119.50 | -0.6% | |
| Mar 22, 2016 | Neal James R76 | VP Business Development | Sell | 19,813 | $0.78 | $15,547.26 | -4.6% | |
| Mar 22, 2016 | Burns Thomas M.76 | VP, Finance &Chief Financial | Sell | 19,249 | $0.78 | $15,104.69 | -9.5% | |
| Mar 22, 2016 | Rubin Paul D | Sr. VP Clinical Dev. &CMO | Sale+OE | 24,194 | $0.78 | $18,985.03 | -6.9% | |
| Mar 22, 2016 | Scannon Patrick J Md Phd | Exec. VP &CSO | Sale+OE | 14,785 | $0.78 | $11,601.79 | -6.1% | |
| Mar 22, 2016 | Varian John | CEO | Sale+OE | 81,022 | $0.78 | $63,577.96 | -6.8% | |
| Feb 1, 2016 | Scannon Patrick J Md Phd | Exec. VP &CSO | Sell | 8,000 | $1.01 | $8,080.00 | -7.8% | |
| Dec 28, 2015 | Scannon Patrick J Md Phd | Exec. VP &CSO | Sell | 8,000 | $1.37 | $10,936.80 | -7.3% | |
| Nov 23, 2015 | Scannon Patrick J Md Phd | Exec. VP &CSO | Sell | 8,000 | $1.35 | $10,800.00 | -6.8% | |
| Oct 26, 2015 | Scannon Patrick J Md Phd | Exec. VP &CSO | Sell | 8,000 | $1.04 | $8,357.60 | -6.3% |